The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study

ABSTRACT Objective: Ventilator-associated pneumonia (VAP) is the leading type of hospital-acquired infection in ICU patients. The diagnosis of VAP is challenging, mostly due to limitations of the diagnostic methods available. The aim of this study was to determine whether antibody-coated bacteria (ACB) evaluation can improve the specificity of endotracheal aspirate (EA) culture in VAP diagnosis. Methods: We conducted a diagnostic case-control study, enrolling 45 patients undergoing mechanical ventilation. Samples of EA were obtained from patients with and without VAP (cases and controls, respectively), and we assessed the number of bacteria coated with FITC-conjugated monoclonal antibodies (IgA, IgM, or IgG) or an FITC-conjugated polyvalent antibody. Using immunofluorescence microscopy, we determined the proportion of ACB among a fixed number of 80 bacteria. Results: The median proportions of ACB were significantly higher among the cases (n = 22) than among the controls (n = 23)-IgA (60.6% vs. 22.5%), IgM (42.5% vs. 12.5%), IgG (50.6% vs. 17.5%), and polyvalent (75.6% vs. 33.8%)-p < 0.001 for all. The accuracy of the best cut-off points for VAP diagnosis regarding monoclonal and polyvalent ACBs was greater than 95.0% and 93.3%, respectively. Conclusions: The numbers of ACB in EA samples were higher among cases than among controls. Our findings indicate that evaluating ACB in EA is a promising tool to improve the specificity of VAP diagnosis. The technique could be cost-effective and therefore useful in low-resource settings, with the advantages of minimizing false-positive results and avoiding overtreatment.

Saved in:
Bibliographic Details
Main Authors: Ranzani,Otavio Tavares, Forte,Daniel Neves, Forte,Antonio Carlos, Mimica,Igor, Forte,Wilma Carvalho Neves
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300203
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1806-37132016000300203
record_format ojs
spelling oai:scielo:S1806-371320160003002032016-06-29The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control studyRanzani,Otavio TavaresForte,Daniel NevesForte,Antonio CarlosMimica,IgorForte,Wilma Carvalho Neves Pneumonia, ventilator-associated/diagnosis Immunohistochemistry Fluorescent antibody technique Antibodies, bacterial/analysis Trachea/microbiology Intensive care units ABSTRACT Objective: Ventilator-associated pneumonia (VAP) is the leading type of hospital-acquired infection in ICU patients. The diagnosis of VAP is challenging, mostly due to limitations of the diagnostic methods available. The aim of this study was to determine whether antibody-coated bacteria (ACB) evaluation can improve the specificity of endotracheal aspirate (EA) culture in VAP diagnosis. Methods: We conducted a diagnostic case-control study, enrolling 45 patients undergoing mechanical ventilation. Samples of EA were obtained from patients with and without VAP (cases and controls, respectively), and we assessed the number of bacteria coated with FITC-conjugated monoclonal antibodies (IgA, IgM, or IgG) or an FITC-conjugated polyvalent antibody. Using immunofluorescence microscopy, we determined the proportion of ACB among a fixed number of 80 bacteria. Results: The median proportions of ACB were significantly higher among the cases (n = 22) than among the controls (n = 23)-IgA (60.6% vs. 22.5%), IgM (42.5% vs. 12.5%), IgG (50.6% vs. 17.5%), and polyvalent (75.6% vs. 33.8%)-p < 0.001 for all. The accuracy of the best cut-off points for VAP diagnosis regarding monoclonal and polyvalent ACBs was greater than 95.0% and 93.3%, respectively. Conclusions: The numbers of ACB in EA samples were higher among cases than among controls. Our findings indicate that evaluating ACB in EA is a promising tool to improve the specificity of VAP diagnosis. The technique could be cost-effective and therefore useful in low-resource settings, with the advantages of minimizing false-positive results and avoiding overtreatment.info:eu-repo/semantics/openAccessSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia v.42 n.3 20162016-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300203en10.1590/S1806-37562015000000244
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ranzani,Otavio Tavares
Forte,Daniel Neves
Forte,Antonio Carlos
Mimica,Igor
Forte,Wilma Carvalho Neves
spellingShingle Ranzani,Otavio Tavares
Forte,Daniel Neves
Forte,Antonio Carlos
Mimica,Igor
Forte,Wilma Carvalho Neves
The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
author_facet Ranzani,Otavio Tavares
Forte,Daniel Neves
Forte,Antonio Carlos
Mimica,Igor
Forte,Wilma Carvalho Neves
author_sort Ranzani,Otavio Tavares
title The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
title_short The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
title_full The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
title_fullStr The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
title_full_unstemmed The value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
title_sort value of antibody-coated bacteria in tracheal aspirates for the diagnosis of ventilator-associated pneumonia: a case-control study
description ABSTRACT Objective: Ventilator-associated pneumonia (VAP) is the leading type of hospital-acquired infection in ICU patients. The diagnosis of VAP is challenging, mostly due to limitations of the diagnostic methods available. The aim of this study was to determine whether antibody-coated bacteria (ACB) evaluation can improve the specificity of endotracheal aspirate (EA) culture in VAP diagnosis. Methods: We conducted a diagnostic case-control study, enrolling 45 patients undergoing mechanical ventilation. Samples of EA were obtained from patients with and without VAP (cases and controls, respectively), and we assessed the number of bacteria coated with FITC-conjugated monoclonal antibodies (IgA, IgM, or IgG) or an FITC-conjugated polyvalent antibody. Using immunofluorescence microscopy, we determined the proportion of ACB among a fixed number of 80 bacteria. Results: The median proportions of ACB were significantly higher among the cases (n = 22) than among the controls (n = 23)-IgA (60.6% vs. 22.5%), IgM (42.5% vs. 12.5%), IgG (50.6% vs. 17.5%), and polyvalent (75.6% vs. 33.8%)-p < 0.001 for all. The accuracy of the best cut-off points for VAP diagnosis regarding monoclonal and polyvalent ACBs was greater than 95.0% and 93.3%, respectively. Conclusions: The numbers of ACB in EA samples were higher among cases than among controls. Our findings indicate that evaluating ACB in EA is a promising tool to improve the specificity of VAP diagnosis. The technique could be cost-effective and therefore useful in low-resource settings, with the advantages of minimizing false-positive results and avoiding overtreatment.
publisher Sociedade Brasileira de Pneumologia e Tisiologia
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300203
work_keys_str_mv AT ranzaniotaviotavares thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT fortedanielneves thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT forteantoniocarlos thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT mimicaigor thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT fortewilmacarvalhoneves thevalueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT ranzaniotaviotavares valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT fortedanielneves valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT forteantoniocarlos valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT mimicaigor valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
AT fortewilmacarvalhoneves valueofantibodycoatedbacteriaintrachealaspiratesforthediagnosisofventilatorassociatedpneumoniaacasecontrolstudy
_version_ 1756431071197528064